A.__Providing the board, another official of the State or a federal official with false or fraudulent records or making false or fraudulent statements regarding a matter within the provisions of this subchapter;

B.__Obtaining or attempting to obtain a prescription drug by fraud, deceit or misrepresentation or engaging in misrepresentation or fraud in the distribution of a prescription drug;

C.__Adulterating, misbranding or counterfeiting a prescription drug;

D.__Manufacturing, repackaging, selling, transferring, delivering, holding or offering for sale a prescription drug that is adulterated, misbranded, counterfeited, suspected of being counterfeited or otherwise unfit for distribution;

E.__Receiving a prescription drug that is adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeited or suspected of being counterfeited and delivering or offering to deliver the prescription drug; and

F.__Altering, mutilating, destroying, obliterating or removing the whole or part of the label of a prescription drug or any other act that misbrands a prescription drug.

2. Penalties.__Notwithstanding the provisions of Title 17-A, section 1301, a violation of this subchapter is a Class B offense for which a fine of up to $50,000 may be adjudged, unless the State proves that the person in violation of this subchapter knowingly violated this subchapter, in which case the violation is a Class A offense for which a penalty of no more that $500,000 may be adjudged.

§13848.__Examination

The board shall develop an examination regarding state and federal laws governing the wholesale distribution of prescription drugs that is to be taken by a designated representative pursuant to section 13843, subsection 3, paragraph C.

§13849. Rules